CD40 Co-Stimulatory Molecule Expression by Dendritic Cells in Primary Atherosclerotic Lesions in Carotid Arteries and in Stenotic Saphenous Vein Coronary Artery Grafts

Vascular

Volumn 9, Issue 4, 2001, Pages 329-333

  Ozmen, J ^a   Bobryshev, Y V ^a   Lord, R S A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

atherosclerosis; carotid arteries; CD40; dendritic cell; S100; saphenous vein coronary bypass grafts

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; PROTEIN S 100;

ADVENTITIA; ARTERY INTIMA; ARTERY MEDIA; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CELL TYPE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DENDRITIC CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREGULATION; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; STENOSIS; T LYMPHOCYTE;

ANTIGENS, CD40; CAROTID ARTERIES; CAROTID STENOSIS; CORONARY ARTERY BYPASS; DENDRITIC CELLS; ENDARTERECTOMY, CAROTID; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; REOPERATION; S100 PROTEINS; VEINS;

EID: 0034966904     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721090100900404     Document Type: Article

References (38)

1. Foy, T. M. Aruffo, A. Bajorath, J. et al. Immune regulation by CD40 and its ligand GP39. Annual Review of Immunology, 1996, 14 591-617.
2. Paulie, S. Ehlin-Henriksson, H. Mellstedt, H. et al. A p50 surface antigen restricted to human urinary bladder carcinoma and B lymphocytes. Cancer Immunology, Immunotherapy, 1985, 20 23-28.
3. Clark, E. A. Ledbetter, J. A. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proceedings of the National Academy of Sciences USA, 1986, 83 4494-4498.
4. Van Kooten, C. Banchereau, J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Advances in Immunology, 1996, 61 1-77.
5. Clark, E. A. CD40: a cytokine receptor in search of a ligand. Tissue Antigens, 1990, 36 33-36.
6. Alderson, M. R. Armitage, R. J. Tough, T. W. et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. Journal of Experimental Medicine, 1993, 178 669-674.
7. Caux, C. Massacrier, C. Vanbervliet, B. et al. Activation of human dendritic cells through CD40 cross-linking. Journal of Experimental Medicine, 1994, 180 1263-1272.
8. Saeland, S. Duvert, V. Caux, C. et al. Distribution of surfacemembrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Experimental Hematology, 1992, 20 24-33.
9. Karmann, K. Hughes, C. W. Schechner, J. et al. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proceedings of the National Academy of Sciences USA, 1995, 92 4342-4346.
10. Hollenbaugh, D. Mischel-Petty, N. Edwards, C. P. et al. Expression of functional CD40 by vascular endothelial cells. Journal of Experimental Medicine, 1995, 182 33-40.
11. Galy, A. H. Spits, H. CD40 is functionally expressed on human thymic epithelium. Journal of Immunology, 1992, 149 775-782.
12. Noelle, R. Snow, E. C. T helper cells. Current Opinion in Immunology, 1992, 4 333-337.
13. Covey, L. R. Cleary, A. M. Yellin, M. J. et al. Isolation of cDNAs encoding T-BAM, a surface glycoprotein on CD4+ T cells mediating contact-dependent helper function for B cells: identity with the CD40-ligand. Molecular Immunology, 1994, 31 471-484.
14. Rousset, F. Garcia, E. Banchereau, J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. Journal of Experimental Medicine, 1991, 173 705-710.
15. Sallusto, F. Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic ceils is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. Journal of Experimental Medicine, 1994, 179 1109-1118.
16. Cella, M. Scheidegger, D. Palmer-Lehmann, K. et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. Journal of Experimental Medicine, 1996, 84 747-752.
17. Bobryshev, Y. V. Lord, R. S. A. S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovascular Research, 1995, 29 689-696.
18. Bobryshev, Y. V. Lord, R. S. A. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovascular Research, 1998, 37 799-810.
19. Cherian, S. M. Bobryshev, Y. V. Inder, S. J. et al. Involvement of dendritic cells in long-term aortocoronary saphenous vein bypass graft failure. Cardiovascular Surgery, 1999, 7 508-518.
20. Banchereau, J. Steinman, R. M. Dendritic cells and the control of immunity. Nature, 1998, 392 245-252.
21. Schonbeck, U. Mach, F. Sukhova, G. K. et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes. A role for CD40 signaling in Plaque rupture? Circulation Research, 1998, 81 448-454.
22. Lanzavecchia, A. Licence to kill. Nature, 1998, 393 413-414.
23. Mach, F. Schonbeck, U. Sukhova, G. K. et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proceedings of the National Academy of Sciences USA, 1997, 94 1931-1936.
24. Mach, F. Schonbeck, U. Boonefoy, J.-Y. et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Circulation, 1997, 96 396-399.
25. Mach, F. Schonbeck, U. Libby, P. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis, 1998, 137 (Suppl.) S89-S95.
26. Mach, F. Schonbeck, U. Sukhova, G. K. et al. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature, 1998, 394 200-203.
27. Grewal, I. S. Flavell, R. A. The CD40 ligand. At the center of the immune universe? Immunologic Research, 1997, 16 59-70.
28. Van Kooten, C. Banchereau, J. Functional role of CD40 and its ligand. International Archives of Allergy and Immunology, 1997, 113 393-399.
29. Laman, J. D. de Smet, B. J. Schoneveld, A. et al. CD40-CD40L interactions in atherosclerosis. Immunology Today, 1997, 18 272-277.
30. Laman, J. D. De Boer, M. Hart, B. A. CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis. Developmental Immunology, 1998, 6 215-222.
31. British Medical Council: Human Experimentation Code of ethics of the World Medical Association and statement on responsibility of investigations on human subjects. British Medical Journal, 1964, 2 177-180.
32. Hsu, S.-M. Raine, L. Fanger, H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry, 1981, 29 577-580.
33. Carbone, A. Gloghini, A. Gattei, V. et al. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood, 1995, 85 780-789.
34. Van den Oord, J. J. Maes, A. Stas, M. et al. CD40 is a prognostic marker in primary cutaneous malignant melanoma. American Journal of Pathology, 1996, 149 1953-1961.
35. Aruffo, A. Farrington, M. Hollenbaugh, D. et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell, 1993, 72 291-300.
36. Gerritse, K. Laman, J. D. Noelle, R. J. et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proceedings of the National Academy of Sciences USA, 1996, 93 2499-2504.
37. Mohan, C. Shi, Y. Laman, J. D. et al. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. Journal of Immunology, 1995, 154 1470-1480.
38. Durie, F. H. Fava, R. A. Foy, T. M. et al. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science, 1993, 261 1328-1330.